This presentation provides an in depth review of the classification system for hallucinogens, the epidemiology of hallucinogen use and an overview of hallucinogen use disorder/hallucinogen intoxication.
After attending, participants will be able to:
- Describe the common classification system for hallucinogens
- Discuss the epidemiology of hallucinogen use
- Define Hallucinogen Use Disorder/Hallucinogen Intoxication
- Report on possible neurobiological reasons for why hallucinogens may present a unique opportunity for treatment of substance related and addictive disorders
- Discuss cautionary considerations in relation to hallucinogen applications in current clinical practice
Jeffrey DeVido, MD, MTS
Chief, Addiction Services
Department of Health and Human Services; Division of Behavioral Health and Recovery Services
Marin County, CA
Dr. DeVido has no relevant disclosures.
This enduring internet activity is jointly provided by the California Society of Addiction Medicine (CSAM) and the California Health Care Foundation. CSAM is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
- 1.00 AMA Category 1
- 1.00 Attendance